Literature DB >> 3723167

A comparison of randomized concurrent control groups with matched historical control groups: are historical controls valid?

L F Diehl, D J Perry.   

Abstract

The use of a historical control group is predicated on the assumption that survival and relapse-free survival in the historical control group closely approximate the survival and relapse-free survival in a randomized concurrent control group. This assumption has never been tested. This study compares survival and relapse-free survival in randomized control groups with historical control groups matched for disease, stage, and follow-up. Of the 43 matched control groups, 42% varied by more than 10 percentage points, 21% varied by more than 20 percentage points, and 5% varied by more than 30 percentage points. Of the 18 that varied by greater than 10 percentage points, 17 had superior survival or relapse-free survival in the randomized concurrent control group. This study indicates that the assumption that historical control groups may replace randomized concurrent control groups is not valid.

Mesh:

Year:  1986        PMID: 3723167     DOI: 10.1200/JCO.1986.4.7.1114

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  11 in total

1.  The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials.

Authors:  R Kunz; A D Oxman
Journal:  BMJ       Date:  1998-10-31

Review 2.  Economic Evaluations of Pharmaceuticals Granted a Marketing Authorisation Without the Results of Randomised Trials: A Systematic Review and Taxonomy.

Authors:  Anthony J Hatswell; Nick Freemantle; Gianluca Baio
Journal:  Pharmacoeconomics       Date:  2017-02       Impact factor: 4.981

Review 3.  Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials.

Authors:  Andrew Anglemyer; Hacsi T Horvath; Lisa Bero
Journal:  Cochrane Database Syst Rev       Date:  2014-04-29

4.  Evidence-based medicine: the fourth revolution in American medicine?

Authors:  Kevin C Chung; Ashwin N Ram
Journal:  Plast Reconstr Surg       Date:  2009-01       Impact factor: 4.730

Review 5.  Radiation Therapy Intensification for Solid Tumors: A Systematic Review of Randomized Trials.

Authors:  Kosj Yamoah; Timothy N Showalter; Nitin Ohri
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-10-19       Impact factor: 7.038

6.  Risk-Adapted Preemptive Tocilizumab to Prevent Severe Cytokine Release Syndrome After CTL019 for Pediatric B-Cell Acute Lymphoblastic Leukemia: A Prospective Clinical Trial.

Authors:  Stephan Kadauke; Regina M Myers; Yimei Li; Richard Aplenc; Diane Baniewicz; David M Barrett; Allison Barz Leahy; Colleen Callahan; Joseph G Dolan; Julie C Fitzgerald; Whitney Gladney; Simon F Lacey; Hongyan Liu; Shannon L Maude; Regina McGuire; Laura S Motley; David T Teachey; Gerald B Wertheim; Lisa Wray; Amanda M DiNofia; Stephan A Grupp
Journal:  J Clin Oncol       Date:  2021-01-08       Impact factor: 44.544

Review 7.  Randomisation to protect against selection bias in healthcare trials.

Authors:  Jan Odgaard-Jensen; Gunn E Vist; Antje Timmer; Regina Kunz; Elie A Akl; Holger Schünemann; Matthias Briel; Alain J Nordmann; Silvia Pregno; Andrew D Oxman
Journal:  Cochrane Database Syst Rev       Date:  2011-04-13

Review 8.  Sample size: how many patients are necessary?

Authors:  P M Fayers; D Machin
Journal:  Br J Cancer       Date:  1995-07       Impact factor: 7.640

9.  Are more observational studies being included in Cochrane Reviews?

Authors:  Hans Christian Kongsted; Merete Konnerup
Journal:  BMC Res Notes       Date:  2012-10-16

Review 10.  Comparison of anticipated and actual control group outcomes in randomised trials in paediatric oncology provides evidence that historically controlled studies are biased in favour of the novel treatment.

Authors:  Veronica Moroz; Jayne S Wilson; Pamela Kearns; Keith Wheatley
Journal:  Trials       Date:  2014-12-10       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.